AEVA CEO files Form 4 for 250,000-share sale via 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Aeva Technologies (AEVA) CEO and Director Soroush Salehian Dardashti reported insider sales on Form 4. On 11/10/2025, a trust for his benefit sold 249,300 shares at a weighted average price of $13.4477 (sold in multiple trades from $12.92 to $13.89) and 700 shares at a weighted average price of $13.9571 (sold in multiple trades from $13.92 to $14.03), pursuant to a Rule 10b5-1 trading plan.
Following these transactions, 1,884,808 shares were beneficially owned indirectly by trust, and 2,093,455 shares were beneficially owned directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 250,000 shares ($3,362,282)
Net Sell
3 txns
Insider
Dardashti Soroush Salehian
Role
Chief Executive Officer
Sold
250,000 shs ($3.36M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 249,300 | $13.4477 | $3.35M |
| Sale | Common Stock | 700 | $13.9571 | $10K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,885,508 shares (Indirect, By trust);
Common Stock — 2,093,455 shares (Direct)
Footnotes (1)
- Represents shares sold in a transaction that was effected automatically pursuant to a Rule 10b5-1 trading plan as previously adopted by the Reporting Person. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $12.92 to $13.89. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $13.92 to $14.03. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
FAQ
What did AEVA (AEVA) disclose in this Form 4?
The CEO and Director reported sales of company common stock executed on 11/10/2025 under a Rule 10b5-1 trading plan.
Were the AEVA insider sales under a 10b5-1 plan?
Yes. The sales were effected automatically pursuant to a previously adopted Rule 10b5-1 trading plan.
What is the insider’s relationship to AEVA?
He is both a Director and the Chief Executive Officer.
What is the transaction date reported?
November 10, 2025.